New therapeutic approaches in irritable bowel syndrome.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003000:Clonidine / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D019936:Probiotics / Q000627:therapeutic use; D011957:Receptors, Opioid / Q000187:drug effects; D018490:Serotonin Agents / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000900:Anti-Bacterial Agents; D011957:Receptors, Opioid; D018490:Serotonin Agents; D013256:Steroids; D003000:Clonidine